1. Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults*  
P. Durando, S.N. Faust, M. Fletcher, P. Krizova, A. Torres, T. Welte 
Clinical Microbiology and Infection 
Volume 19, Pages 1-9 (October 2013)
DOI: /
Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

2. FIG. 1
Schematic representation of how, for a given type of clinical presentation, the fraction attributable to bacteria, Streptococcus pneumoniae and vaccine serotypes may vary. This phenomenon can explain how the impact on the different clinical presentations can vary also.
Clinical Microbiology and Infection  , 1-9DOI: ( / )
Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions